Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
C$0.00
C$7.13
C$590.00
C$317.06MN/A8,002 shs921 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
C$39.91M0.00N/A3.94C$6.07 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A-C$63.06N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
37.47
4.06
3.66

Institutional Ownership

CompanyInstitutional Ownership
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A

Insider Ownership

CompanyInsider Ownership
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
48723.31 millionN/ANot Optionable

Recent News About These Companies

Rethinking rare diseases: treat the whole patient
Panetta Institute for Public Policy
2024 Breakthrough Prizes in Life Sciences
TMC Life Sciences Bhd (TMCN)
Life Sciences Learning Community
Chicago Life Sciences Summit
College of Liberal Arts & Sciences
WEF, Telangana joins hands to start thematic centre on healthcare and life sciences
Working on PLI schemes for more sectors: Piyush Goyal
TSX:CVE (CENOVUS ENERGY INC.)

Top Headlines

View All Headlines
ProMetic Life Sciences stock logo

ProMetic Life Sciences TSE:PLI

Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.